Tiagabine withdrawal-emergent mania.
Pushpal
Desarkar
D
Shamshul
Haque Nizamie
HN
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000188:drug therapy; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004569:Electroencephalography / Q000187:drug effects; D017029:Epilepsy, Complex Partial / Q000188:drug therapy*; D018755:GABA Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009557:Nipecotic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000077152:Olanzapine; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*; D000078308:Tiagabine
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D018755:GABA Agonists; D009557:Nipecotic Acids; D001569:Benzodiazepines; D002220:Carbamazepine; D000077152:Olanzapine; D000078308:Tiagabine